These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7946750)

  • 1. Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance.
    Hasenfuss G; Just H
    Br Heart J; 1994 Aug; 72(2 Suppl):S10-7. PubMed ID: 7946750
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic neurohumors in the heart of hamsters with hereditary myopathy during cardiac hypertrophy and failure.
    Angelakos ET; Carballo LC; Daniels JB; King MP; Bajusz E
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():262-78. PubMed ID: 4283440
    [No Abstract]   [Full Text] [Related]  

  • 3. The myocardium in congestive heart failure.
    Katz AM
    Am J Cardiol; 1989 Jan; 63(2):12A-16A. PubMed ID: 2521266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological remodeling in hypertrophy and heart failure.
    Tomaselli GF; Marbán E
    Cardiovasc Res; 1999 May; 42(2):270-83. PubMed ID: 10533566
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin-like growth factor I and cardiac performance in heart failure.
    Donath MY; Froesch ER; Zapf J
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():167-70. PubMed ID: 10990156
    [No Abstract]   [Full Text] [Related]  

  • 7. CaMKII and a failing strategy for growth in heart.
    Anderson ME
    J Clin Invest; 2009 May; 119(5):1082-5. PubMed ID: 19422097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myocardium in hyperfunction, hypertrophy and heart failure.
    Meerson FZ
    Circ Res; 1969 Jul; 25(1):Suppl 2:1-163. PubMed ID: 4240407
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and heart failure.
    Singh N; Dhalla AK; Seneviratne C; Singal PK
    Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):77-81. PubMed ID: 7494558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocyte death and growth in the failing heart.
    Anversa P; Leri A; Beltrami CA; Guerra S; Kajstura J
    Lab Invest; 1998 Jul; 78(7):767-86. PubMed ID: 9690556
    [No Abstract]   [Full Text] [Related]  

  • 12. Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?
    Balakumar P; Singh AP; Ganti SS; Krishan P; Ramasamy S; Singh M
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):5-9. PubMed ID: 17973902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early ultrastructural and biochemical changes in the myopathic hamster heart.
    Nadkarni BB; Hunt B; Heggtveit HA
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():251-61. PubMed ID: 4283439
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic remodeling in hypertrophied and failing myocardium: a review.
    Peterzan MA; Lygate CA; Neubauer S; Rider OJ
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H597-H616. PubMed ID: 28646030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial oxygen consumption during experimental hypertrophy and congestive heart failure.
    Gunning JF; Coleman HN
    J Mol Cell Cardiol; 1973 Feb; 5(1):25-38. PubMed ID: 4266588
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of metabolic dysfunction on cardiac mechanics in decompensated hypertrophy and heart failure.
    Tewari SG; Bugenhagen SM; Vinnakota KC; Rice JJ; Janssen PML; Beard DA
    J Mol Cell Cardiol; 2016 May; 94():162-175. PubMed ID: 27085901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology of the acute and chronic heart dilatation and cardiac insufficiency].
    Hort W
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():1-15. PubMed ID: 4242130
    [No Abstract]   [Full Text] [Related]  

  • 19. Signaling pathways for cardiac hypertrophy and failure.
    Hunter JJ; Chien KR
    N Engl J Med; 1999 Oct; 341(17):1276-83. PubMed ID: 10528039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemical problems in cardiac hypertrophy and chronic insufficiency].
    Swynghedauw B
    Nouv Presse Med; 1979 Oct; 8(38):3021-4. PubMed ID: 160541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.